0000950170-24-042297.txt : 20240405 0000950170-24-042297.hdr.sgml : 20240405 20240405163313 ACCESSION NUMBER: 0000950170-24-042297 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240329 FILED AS OF DATE: 20240405 DATE AS OF CHANGE: 20240405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Slebir John L CENTRAL INDEX KEY: 0001475990 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34207 FILM NUMBER: 24826979 MAIL ADDRESS: STREET 1: C/O VIVUS, INC. STREET 2: 351 EAST EVELYN AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94041 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DYNAVAX TECHNOLOGIES CORP CENTRAL INDEX KEY: 0001029142 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 330728374 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2100 POWELL STREET STREET 2: SUITE 720 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 5108485100 MAIL ADDRESS: STREET 1: 2100 POWELL STREET STREET 2: SUITE 720 CITY: EMERYVILLE STATE: CA ZIP: 94608 3 1 ownership.xml 3 X0206 3 2024-03-29 0 0001029142 DYNAVAX TECHNOLOGIES CORP DVAX 0001475990 Slebir John L C/O DYNAVAX TECHNOLOGIES 2100 POWELL STREET, SUITE 720 EMERYVILLE CA 94608 false true false false SVP General Counsel Common Stock 10085 D Stock Option (Right to Buy) 9.29 2028-06-27 Common Stock 300000 D Stock Options (Right to Buy) 12.74 2029-02-09 Common Stock 80000 D Restricted Stock Unit Common Stock 14000 D Stock Options (Right to Buy) 11.12 2030-02-15 Common Stock 88000 D Stock Options (Right to Buy) 12.48 2031-02-14 Common Stock 70000 D Restricted Stock Unit Common Stock 50000 D This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of June 28, 2021, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter. This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of February 10, 2022, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter. Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 10, 2022. This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of February 16, 2023, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter. This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of February 15, 2024, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter. Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 15, 2024. /s/ JOHN SLEBIR 2024-04-05